Yıldız, F. and Öksüzoğlu, B. 2020. Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. Journal of Surgery and Medicine. 4, 6 (Jun. 2020), 443–446. DOI:https://doi.org/10.28982/josam.745731.